Nutritional Health LTP Fund General Partner LLC - 10%+ Owner at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity type: Company
Role: 10%+ Owner
Issuer symbol: MCRB on Nasdaq
Source filings: Open source filing history

There are no Buy or Sell transactions made by Nutritional Health LTP Fund General Partner LLC since 31 May 2025

Holdings reported by Nutritional Health LTP Fund General Partner LLC for Seres Therapeutics, Inc.

Form 4 holding 10%+ Owner

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 5,875,711
Estimated value: $7,932,210
Report date: 05 Jul 2022
Price: $1.35
Ownership: By Nutritional Health LTP Fund, L.P.

Form 4 holding 10%+ Owner

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 5,825,495
Estimated value: $7,864,418
Report date: 05 Jul 2022
Price: $1.35
Ownership: By Flagship Pioneering Fund VII, L.P.

Form 4 holding 10%+ Owner

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 4,434,600
Estimated value: $5,986,710
Report date: 05 Jul 2022
Price: $1.35
Ownership: By Flagship Ventures Fund IV, L.P.

Form 4 holding 10%+ Owner

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 2,962,963
Estimated value: $4,000,000
Report date: 05 Jul 2022
Price: $1.35
Ownership: By Flagship Pioneering Fund VI, L.P.

Form 4 holding 10%+ Owner

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 2,734,994
Estimated value: $3,692,242
Report date: 05 Jul 2022
Price: $1.35
Ownership: By Flagship VentureLabs IV LLC

Form 4 holding 10%+ Owner

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 1,283,282
Estimated value: $1,732,431
Report date: 05 Jul 2022
Price: $1.35
Ownership: By Flagship Ventures Fund IV-Rx, L.P.

Form 4 holding 10%+ Owner

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 376,018
Estimated value: $507,624
Report date: 05 Jul 2022
Price: $1.35
Ownership: By Noubar B. Afeyan, Ph.D.

Transactions reported by Nutritional Health LTP Fund General Partner LLC for Seres Therapeutics, Inc.

Sym	Class	Transaction	%	Reported value	Reported price	Shares	Shares after	Date	Ownership

^* indicates a reported price that failed the local validity check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .